Abstract
Caffeine is the most frequently consumed psychoactive substance in the world. Despite its safety, caffeine consumption has been linked to negative consequences on mood. Here, we describe the effects of caffeine consumption on anxiety-related behaviors. These effects are dependent of several factors such as tolerance, genetic polymorphism, mental health status, sex, and age. Special attention will be paid to the effects of caffeine during pregnancy and adolescence. This chapter also addresses mechanisms associated with the effects of caffeine on anxiety, which are, at least in part, mediated by adenosine receptors. Polymorphisms in genes controlling the expression of these receptors have been implicated in susceptibility to anxiety caused by caffeine consumption. Caffeine use and anxiety in patients with mental disorders will also be addressed. The issues that have already been identified regarding caffeine effects on anxiety recommends moderation in its consumption and should guide policy formulation by drug/food regulatory agencies.
This is a preview of subscription content, log in via an institution to check access.
Abbreviations
- A1R:
-
Adenosine receptor A1
- A2R:
-
Adenosine receptor A2
- BDNF:
-
Brain-derived neurotrophic factor
- BNST:
-
Bed nucleus of stria terminalis
- CPA:
-
N6-Cyclopentyladenosine
- CREB:
-
cAMP-response element-binding protein
- DASS-21:
-
Self-reported Depression Anxiety Stress Scale
- ED:
-
Energy drinks
- fMRI:
-
Functional magnetic resonance imaging
- GABA:
-
γ-aminobutyric acid
- GAD-7:
-
Generalized Anxiety Disorder-7 scale
- GFP:
-
Green fluorescent protein
- HPA:
-
Hypothalamic–pituitary–adrenal
- MC4:
-
Melanocortin-4
- MEG:
-
Source-localized magnetoencephalography
- NPSR:
-
Neuropeptide S receptor
- PET:
-
Positron emission tomography
- POMS:
-
Profile of Mood States questionnaire
- PVN:
-
Paraventricular hypothalamic nucleus
- α-MSH:
-
Alpha-melanocyte stimulating hormone
References
Abrams JK et al (2005) Serotonergic systems associated with arousal and vigilance behaviors following administration of anxiogenic drugs. Neuroscience 133(4):983–997. https://doi.org/10.1016/j.neuroscience.2005.03.025
Adan A et al (2008) Early effects of caffeinated and decaffeinated coffee on subjective state and gender differences. Prog Neuro-Psychopharmacol Biol Psychiatry 32(7):1698–1703. https://doi.org/10.1016/j.pnpbp.2008.07.005
Alhowail A, Aldubayan M (2020) Mechanisms underlying cognitive impairment induced by prenatal caffeine exposure. Eur Rev Med Pharmacol Sci 24(22):11909–11913. https://doi.org/10.26355/eurrev_202011_23849
Alsene K et al (2003) Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28(9):1694–1702. https://doi.org/10.1038/sj.npp.1300232
Altemus M, Sarvaiya N, Neill Epperson C (2014) Sex differences in anxiety and depression clinical perspectives. Front Neuroendocrinol 35(3):320–330. https://doi.org/10.1016/j.yfrne.2014.05.004
Arnold MR et al (2019) Effects of chronic caffeine exposure during adolescence and subsequent acute caffeine challenge during adulthood on rat brain serotonergic systems. Neuropharmacology 148:257–271. https://doi.org/10.1016/j.neuropharm.2018.12.019
Babu KM, Church RJ, Lewander W (2008) Energy drinks: the new eye-opener for adolescents. Clin Pediatr Emerg Med 9(1):35–42. https://doi.org/10.1016/j.cpem.2007.12.002
Berglundh S et al (2021) Maternal caffeine intake during pregnancy and child neurodevelopment up to eight years of age – results from the Norwegian mother, father and child cohort study. Eur J Nutr 60(2):791–805. https://doi.org/10.1007/s00394-020-02280-7
Bernstein GA et al (2002) Caffeine dependence in teenagers. Drug Alcohol Depend 66(1):1–6. https://doi.org/10.1016/S0376-8716(01)00181-8
Bertasi RAO et al (2021) Caffeine intake and mental health in college students. Cureus 13(4):e14313. https://doi.org/10.7759/cureus.14313
Bhorkar AA et al (2014) Involvement of the central melanocortin system in the effects of caffeine on anxiety-like behavior in mice. Life Sci 95(2):72–80. https://doi.org/10.1016/j.lfs.2013.12.014
Botella P, Parra A (2003) Coffee increases state anxiety in males but not in females. Hum Psychopharmacol 18(2):141–143. https://doi.org/10.1002/hup.444
Carrillo JA, Benitez J (2000) Clinically significant pharmacokinetic interactions between dietary caffeine and medications. Clin Pharmacokinet 39(2):127–153. https://doi.org/10.2165/00003088-200039020-00004
Chang D et al (2018) Caffeine caused a widespread increase of resting brain entropy. Sci Rep 8(1):2700. https://doi.org/10.1038/s41598-018-21008-6
Chelben J et al (2008) Effects of amino acid energy drinks leading to hospitalization in individuals with mental illness. Gen Hosp Psychiatry 30(2):187–189. https://doi.org/10.1016/j.genhosppsych.2007.10.002
Childs E et al (2008) Association between ADORA2A and DRD2 polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 33(12):2791–2800. https://doi.org/10.1038/npp.2008.17
Chtourou H et al (2019) Acute effects of an “energy drink” on short-term maximal performance, reaction times, psychological and physiological parameters: insights from a randomized double-blind, placebo-controlled, counterbalanced crossover trial. Nutrients 11(5). https://doi.org/10.3390/nu11050992
da Silva Gonçalves B et al (2019) Lifelong exposure to caffeine increases anxiety-like behavior in adult mice exposed to tobacco smoke during adolescence. Neurosci Lett 696:146. https://doi.org/10.1016/j.neulet.2018.12.026
de Carvalho TS et al (2019) Oxidative stress mediates anxiety-like behavior induced by high caffeine intake in zebrafish: protective effect of alpha-tocopherol. Oxidative Med Cell Longev 2019:1–9. https://doi.org/10.1155/2019/8419810
Deckert J (1998) The adenosine A2A receptor knockout mouse: a model for anxiety? Int J Neuropsychopharmacol 1(2):S1461145798001217. https://doi.org/10.1017/S1461145798001217
Domschke K et al (2012) Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation. Psychopharmacology 222(3):533–541. https://doi.org/10.1007/s00213-012-2678-0
Dosh T et al (2010) A comparison of the associations of caffeine and cigarette use with depressive and ADHD symptoms in a sample of young adult smokers. J Addict Med 4(1):52–54. https://doi.org/10.1097/ADM.0b013e3181b508ec
El Yacoubi M et al (2000) The anxiogenic-like effect of caffeine in two experimental procedures measuring anxiety in the mouse is not shared by selective A 2A adenosine receptor antagonists. Psychopharmacology 148(2):153–163. https://doi.org/10.1007/s002130050037
European Food Safety Authority (EFSA) (2015) Scientific opinion on the safety of caffeine. EFSA panel on dietetic products, nutrition and allergies (NDA). EFSA J 13(5):4102
Fiani B et al (2021) The neurophysiology of caffeine as a central nervous system stimulant and the resultant effects on cognitive function. Cureus 13(5):e15032. https://doi.org/10.7759/cureus.15032
Florio C et al (1998) Adenosine A 1 receptors modulate anxiety in CD1 mice. Psychopharmacology 136(4):311–319. https://doi.org/10.1007/s002130050572
Fuller DT, Smith ML, Boolani A (2021) Trait energy and fatigue modify the effects of caffeine on mood, cognitive and fine-motor task performance: a post-hoc study. Nutrients 13(2):412. https://doi.org/10.3390/nu13020412
Fulton JL et al (2018) Impact of genetic variability on physiological responses to caffeine in humans: a systematic review. Nutrients 10(10). https://doi.org/10.3390/nu10101373
Gajewska A et al (2013) Effects of ADORA2A gene variation and caffeine on prepulse inhibition: a multi-level risk model of anxiety. Prog Neuro-Psychopharmacol Biol Psychiatry 40:115–121. https://doi.org/10.1016/j.pnpbp.2012.08.008
Giménez-Llort L et al (2002) Mice lacking the adenosine A 1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur J Neurosci 16(3):547–550. https://doi.org/10.1046/j.1460-9568.2002.02122.x
Gray B, Das K, J. and Semsarian, C. (2012) Consumption of energy drinks: a new provocation test for primary arrhythmogenic diseases? Int J Cardiol 159(1):77–78. https://doi.org/10.1016/j.ijcard.2012.05.121
Grosso LM, Bracken MB (2005) Caffeine metabolism, genetics, and perinatal outcomes: a review of exposure assessment considerations during pregnancy. Ann Epidemiol 15(6):460–466. https://doi.org/10.1016/j.annepidem.2004.12.011
Guest NS et al (2021) International society of sports nutrition position stand: caffeine and exercise performance. J Int Soc Sports Nutr 18(1):1. https://doi.org/10.1186/s12970-020-00383-4
Hale MW et al (2010) Multiple anxiogenic drugs recruit a parvalbumin-containing subpopulation of GABAergic interneurons in the basolateral amygdala. Prog Neuro-Psychopharmacol Biol Psychiatry 34(7):1285–1293. https://doi.org/10.1016/j.pnpbp.2010.07.012
Harris JL, Munsell CR (2015) Energy drinks and adolescents: what’s the harm? Nutr Rev 73(4):247–257. https://doi.org/10.1093/nutrit/nuu061
Hohoff C et al (2010) Adenosine A2A receptor gene: evidence for association of risk variants with panic disorder and anxious personality. J Psychiatr Res 44(14):930–937. https://doi.org/10.1016/j.jpsychires.2010.02.006
Hughes RN (2011) Adult anxiety-related behavior of rats following consumption during late adolescence of alcohol alone and in combination with caffeine. Alcohol 45(4):365–372. https://doi.org/10.1016/j.alcohol.2010.10.006
Hughes RN et al (2014) Evidence for anxiolytic effects of acute caffeine on anxiety-related behavior in male and female rats tested with and without bright light. Behav Brain Res 271:7–15. https://doi.org/10.1016/j.bbr.2014.05.038
Hvolgaard Mikkelsen S et al (2017) Maternal caffeine consumption during pregnancy and behavioral disorders in 11-year-old offspring: a Danish National Birth Cohort Study. J Pediatr 189:120–127.e1. https://doi.org/10.1016/j.jpeds.2017.06.051
Institute of Medicine (IOM) (2014) Caffeine in food and dietary supplements: examining safety: workshop summary. National Academies Press. www.nap.edu
Jain N et al (1995) Anxiolytic activity of adenosine receptor activation in mice. Br J Pharmacol 116(3):2127–2133. https://doi.org/10.1111/j.1476-5381.1995.tb16421.x
Jee HJ et al (2020) Effect of caffeine consumption on the risk for neurological and psychiatric disorders: sex differences in human. Nutrients 12(10). https://doi.org/10.3390/nu12103080
Johansson B et al (2001) Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci 98(16):9407–9412. https://doi.org/10.1073/pnas.161292398
Kaur S et al (2020) Consumption of energy drinks is associated with depression, anxiety, and stress in young adult males: evidence from a longitudinal cohort study. Depress Anxiety 37(11):1089–1098. https://doi.org/10.1002/da.23090
Kendler KS, Myers J, Gardner CO (2006) Caffeine intake, toxicity and dependence and lifetime risk for psychiatric and substance use disorders: an epidemiologic and co-twin control analysis. Psychol Med 36(12):1717–1725. https://doi.org/10.1017/S0033291706008622
Khurana K, Bansal N (2019) Lacidipine attenuates caffeine-induced anxiety-like symptoms in mice: role of calcium-induced oxido-nitrosative stress. Pharmacol Rep 71(6):1264–1272. https://doi.org/10.1016/j.pharep.2019.07.008
Knutti R, Rothweiler H, Schlatter C (1982) The effect of pregnancy on the pharmacokinetics of caffeine. 187–192. https://doi.org/10.1007/978-3-642-68511-8_33
Krahe TE et al (2017) Energy drink enhances the behavioral effects of alcohol in adolescent mice. Neurosci Lett 651. https://doi.org/10.1016/j.neulet.2017.04.050
Laatar R et al (2021) Caffeine consumption improves motor and cognitive performances during dual tasking in middle-aged women. Behav Brain Res 412:113437. https://doi.org/10.1016/j.bbr.2021.113437
Laureano-Melo R et al (2016) Behavioral profile assessment in offspring of Swiss mice treated during pregnancy and lactation with caffeine. Metab Brain Dis 31(5):1071–1080. https://doi.org/10.1007/s11011-016-9847-5
León D et al (2002) Adenosine A1 receptor down-regulation in mothers and fetal brain after caffeine and theophylline treatments to pregnant rats. J Neurochem 82(3):625–634. https://doi.org/10.1046/j.1471-4159.2002.01008.x
León D et al (2005) Effect of chronic gestational treatment with caffeine or theophylline on Group I metabotropic glutamate receptors in maternal and fetal brain. J Neurochem 94(2):440–451. https://doi.org/10.1111/j.1471-4159.2005.03211.x
Leonard SK et al (2008) Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders. Psychopharmacology 197(4):601–611. https://doi.org/10.1007/s00213-008-1080-4
Loomans EM et al (2012) Caffeine intake during pregnancy and risk of problem behavior in 5-to 6-year-old children. Pediatrics 130(2):e305–e313. https://doi.org/10.1542/peds.2011-3361
Lorenzo AM et al (2010) Maternal caffeine intake during gestation and lactation down-regulates adenosine A 1 receptor in rat brain from mothers and neonates. J Neurosci Res 88(6):1252–1261. https://doi.org/10.1002/jnr.22287
Luebbe AM (2011) Child and adolescent anxiety sensitivity, perceived subjective effects of caffeine and caffeine consumption. J Caffeine Res 1(4):213–218. https://doi.org/10.1089/jcr.2011.0020
Luebbe AM, Bell DJ (2009) Mountain dew ® or mountain don’t?: a pilot investigation of caffeine use parameters and relations to depression and anxiety symptoms in 5th- and 10th-grade students. J Sch Health 79(8):380–387. https://doi.org/10.1111/j.1746-1561.2009.00424.x
Magalhães R et al (2021) Habitual coffee drinkers display a distinct pattern of brain functional connectivity. Mol Psychiatry. https://doi.org/10.1038/s41380-021-01075-4
Marmorstein NR (2016) Energy drink and coffee consumption and psychopathology symptoms among early adolescents: cross-sectional and longitudinal associations. J Caffeine Res 6(2):64–72. https://doi.org/10.1089/jcr.2015.0018
Masdrakis VG et al (2008) Caffeine challenge in patients with panic disorder: baseline differences between those who panic and those who do not. Depress Anxiety 25(9):E72–E79. https://doi.org/10.1002/da.20333
Matovu D, Alele PE (2018) Seizure vulnerability and anxiety responses following chronic co-administration and acute withdrawal of caffeine and ethanol in a rat model. J Basic Clin Physiol Pharmacol 29(1):1–10. https://doi.org/10.1515/jbcpp-2017-0018
McLellan TM, Lieberman HR (2012) Do energy drinks contain active components other than caffeine? Nutr Rev 70(12):730–744. https://doi.org/10.1111/j.1753-4887.2012.00525.x
Mioranzza S et al (2014) Prenatal caffeine intake differently affects synaptic proteins during fetal brain development. Int J Dev Neurosci 36(1):45–52. https://doi.org/10.1016/j.ijdevneu.2014.04.006
Naftalovich H, Tauber N, Kalanthroff E (2020) But first, coffee: the roles of arousal and inhibition in the resistance of compulsive cleansing in individuals with high contamination fears. J Anxiety Disord 76:102316. https://doi.org/10.1016/j.janxdis.2020.102316
Nardi AE et al (2007) Caffeine challenge test in panic disorder and depression with panic attacks. Compr Psychiatry 48(3):257–263. https://doi.org/10.1016/j.comppsych.2006.12.001
Nardi AE et al (2009) Panic disorder and social anxiety disorder subtypes in a caffeine challenge test. Psychiatry Res 169(2):149–153. https://doi.org/10.1016/j.psychres.2008.06.023
Nehlig A (2018) Interindividual differences in caffeine metabolism and factors driving caffeine consumption. Pharmacol Rev 70(2):384–411. https://doi.org/10.1124/pr.117.014407
Nicholson SA (1989) Stimulatory effect of caffeine on the hypothalamo-pituitary-adrenocortical axis in the rat. J Endocrinol 122(2):535–543. https://doi.org/10.1677/joe.0.1220535
Nowak D, Jasionowski A (2016) Analysis of consumption of energy drinks by a group of adolescent athletes. Int J Environ Res Public Health 13(8):768. https://doi.org/10.3390/ijerph13080768
O’Neill CE et al (2016) Adolescent caffeine consumption increases adulthood anxiety-related behavior and modifies neuroendocrine signaling. Psychoneuroendocrinology 67:40–50. https://doi.org/10.1016/j.psyneuen.2016.01.030
Okada M et al (1999) Differential effects of adenosine receptor subtypes on release and reuptake of hippocampal serotonin. Eur J Neurosci 11(1):1–9. https://doi.org/10.1046/j.1460-9568.1999.00415.x
Pan H-Z, Chen H-H (2007) Hyperalgesia, low-anxiety, and impairment of avoidance learning in neonatal caffeine-treated rats. Psychopharmacology 191(1):119–125. https://doi.org/10.1007/s00213-006-0613-y
Park C-A et al (2014) The effects of caffeine ingestion on cortical areas: functional imaging study. Magn Reson Imaging 32(4):366–371. https://doi.org/10.1016/j.mri.2013.12.018
Patki G et al (2015) Tempol treatment reduces anxiety-like behaviors induced by multiple Anxiogenic drugs in rats. PLos One 10(3):e0117498. https://doi.org/10.1371/journal.pone.0117498. Edited by A. Kavushansky
Patz MD et al (2006) Modulation of the hypothalamo–pituitary–adrenocortical axis by caffeine. Psychoneuroendocrinology 31(4):493–500. https://doi.org/10.1016/j.psyneuen.2005.11.008
Peng T-I, Jou M-J (2010) Oxidative stress caused by mitochondrial calcium overload. Ann N Y Acad Sci 1201:183–188. https://doi.org/10.1111/j.1749-6632.2010.05634.x
Pennington N et al (2010) Energy drinks: a new health hazard for adolescents. J Sch Nurs 26(5):352–359. https://doi.org/10.1177/1059840510374188
Richards G, Smith A (2015) Caffeine consumption and self-assessed stress, anxiety, and depression in secondary school children. J Psychopharmacol 29(12):1236–1247. https://doi.org/10.1177/0269881115612404
Rogers PJ et al (2010) Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption. Neuropsychopharmacology 35(9):1973–1983. https://doi.org/10.1038/npp.2010.71
Rorabaugh BR (2021) Does prenatal exposure to CNS stimulants increase the risk of cardiovascular disease in adult offspring? Front Cardiovasc Med 8. https://doi.org/10.3389/fcvm.2021.652634
Savchenko VL, Boughter JD (2011) Regulation of neuronal activation by Alpha2A adrenergic receptor agonist. Neurotox Res 20(3):226–239. https://doi.org/10.1007/s12640-010-9236-5
Seifert SM et al (2011) Health effects of energy drinks on children, adolescents, and young adults. Pediatrics 127(3):511–528. https://doi.org/10.1542/peds.2009-3592
Silva RS et al (2008) Maternal caffeine intake affects acetylcholinesterase in hippocampus of neonate rats. Int J Dev Neurosci 26(3–4):339–343. https://doi.org/10.1016/j.ijdevneu.2007.12.006
Silva CG et al (2013) Adenosine receptor antagonists including caffeine alter fetal brain development in mice. Sci Transl Med 5(197):197ra104. https://doi.org/10.1126/scitranslmed.3006258
Sweeney P et al (2016) Caffeine increases food intake while reducing anxiety-related behaviors. Appetite 101:171–177. https://doi.org/10.1016/j.appet.2016.03.013
Tal O et al (2013) Caffeine-induced global reductions in resting-state BOLD connectivity reflect widespread decreases in MEG connectivity. Front Hum Neurosci 7:63. https://doi.org/10.3389/fnhum.2013.00063
Tchekalarova JD, Kubová H, Mareš P (2014) Early caffeine exposure: transient and long-term consequences on brain excitability. Brain Res Bull 104:27–35. https://doi.org/10.1016/j.brainresbull.2014.04.001
Temple JL, Ziegler AM (2011) Gender differences in subjective and physiological responses to caffeine and the role of steroid hormones. J Caffeine Res 1(1):41–48. https://doi.org/10.1089/jcr.2011.0005
Temple JL et al (2009) Sex differences in reinforcing value of caffeinated beverages in adolescents. Behav Pharmacol 20(8):731–741. https://doi.org/10.1097/FBP.0b013e328333b27c
Trapp GSA et al (2014) Energy drink consumption is associated with anxiety in Australian young adult males. Depress Anxiety 31(5):420–428. https://doi.org/10.1002/da.22175
Tremblay L et al (2015) Selective dysfunction of basal ganglia subterritories: from movement to behavioral disorders. Mov Disord 30(9):1155–1170. https://doi.org/10.1002/mds.26199
Tung R et al (2021) Functional connectivity within an anxiety network and associations with anxiety symptom severity in middle-aged adults with and without autism. Autism Res. https://doi.org/10.1002/aur.2579
Turnbull D, Rodricks JV, Mariano GF (2016) Neurobehavioral hazard identification and characterization for caffeine. Regul Toxicol Pharmacol 74:81–92. https://doi.org/10.1016/j.yrtph.2015.12.002
Turner S et al (2018) Self-medication with alcohol or drugs for mood and anxiety disorders: a narrative review of the epidemiological literature. Depress Anxiety 35(9):851–860. https://doi.org/10.1002/da.22771
van Calker D et al (2019) The role of adenosine receptors in mood and anxiety disorders. J Neurochem 151(1):11–27. https://doi.org/10.1111/jnc.14841
Whalen DJ et al (2007) Caffeine consumption, sleep, and affect in the natural environments of depressed youth and healthy controls. J Pediatr Psychol 33(4):358–367. https://doi.org/10.1093/jpepsy/jsm086
Willson C (2018) The clinical toxicology of caffeine: a review and case study. Toxicol Rep 5:1140–1152. https://doi.org/10.1016/j.toxrep.2018.11.002
Wong CW et al (2012) Anti-correlated networks, global signal regression, and the effects of caffeine in resting-state functional MRI. NeuroImage 63(1):356–364. https://doi.org/10.1016/j.neuroimage.2012.06.035
Xu TJ, Reichelt AC (2018) Sucrose or sucrose and caffeine differentially impact memory and anxiety-like behaviours, and alter hippocampal parvalbumin and doublecortin. Neuropharmacology 137:24–32. https://doi.org/10.1016/j.neuropharm.2018.04.012
Xu Y-L et al (2007) Distribution of neuropeptide S receptor mRNA and neurochemical characteristics of neuropeptide S-expressing neurons in the rat brain. J Comp Neurol 500(1):84–102. https://doi.org/10.1002/cne.21159
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this entry
Cite this entry
Ribeiro-Carvalho, A., Dutra-Tavares, A.C., Filgueiras, C.C., Manhães, A.C., Abreu-Villaça, Y. (2022). Caffeine and Anxiety-Like Behavior. In: Patel, V.B., Preedy, V.R. (eds) Handbook of Substance Misuse and Addictions. Springer, Cham. https://doi.org/10.1007/978-3-030-67928-6_80-1
Download citation
DOI: https://doi.org/10.1007/978-3-030-67928-6_80-1
Received:
Accepted:
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-67928-6
Online ISBN: 978-3-030-67928-6
eBook Packages: Springer Reference MedicineReference Module Medicine